NEW YORK, Jan. 2 — Panacea Pharmaceuticals has added former US Food & Drug Administration commissioner Frank Young to its board of directors, the company said Wednesday. Young, with expertise in genetics, biotechnology, regulatory issues and defense applications of bioscience, will help guide the company's efforts to use functional genomics in developing new therapeutics and diagnostics for cancer and central nervous system diseases.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.